Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Kedudukan dalam Saham #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Harga Saham
$0.21291741
Disegerakkan terakhir: 2025-04-18
Modal Pasaran
$12.07M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan PCL, Inc. (241820)

Kategori

Healthcare
Nisbah P/E bagi PCL, Inc. (241820)
Nisbah P/E pada August 2026 TTM: -76.46
Menurut laporan kewangan dan harga saham terkini PCL, Inc., nisbah P/E semasa (TTM) ialah -76.46. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -7.57.
Sejarah nisbah P/E bagi PCL, Inc. dari 2015 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -76.46 12,858.59%
2024 -0.59 -92.15%
2023 -7.57 -82.84%
2022 -44.09 246.03%
2021 -12.74 -163.14%
2020 20.18 -296.84%
2019 -10.25 -38.00%
2018 -16.54 -62.71%
2017 -44.35 13.31%
2016 -39.14 -20.35%
2015 -49.14 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -146.79%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -145.60%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -127.97%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -127.34%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -168.86%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.